Agios Pharmaceuticals Inc’s recent filing unveils that its Officer Gheuens Sarah acquired Company’s shares for reported $0.14 million on Jul 01 ’25. In the deal valued at $34.37 per share,4,091 shares were bought.
Then, Burns James William sold 2,799 shares, generating $93,878 in total proceeds. Upon selling the shares at $33.54, the Chief Legal Officer now owns 28,650 shares.
Before that, Gheuens Sarah sold 2,909 shares. Agios Pharmaceuticals Inc shares valued at $97,568 were divested by the Chief Medical Officer at a price of $33.54 per share. As a result of the transaction, Gheuens Sarah now holds 56,988 shares, worth roughly $1.96 million.
H.C. Wainwright initiated its Agios Pharmaceuticals Inc [AGIO] rating to a Buy in a research note published on February 24, 2025; the price target was $58. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in mid October with a ‘”a Sector outperform”‘ rating. Leerink Partners revised its rating on September 27, 2024. It rated AGIO as “a Market perform” which previously was an “an Outperform”.
Price Performance Review of AGIO
On Tuesday, Agios Pharmaceuticals Inc [NASDAQ:AGIO] saw its stock jump 3.34% to $34.37. Over the last five days, the stock has gained 2.84%. Agios Pharmaceuticals Inc shares have fallen nearly -21.19% since the year began. Nevertheless, the stocks have risen 4.60% over the past one year. While a 52-week high of $62.58 was reached on 06/16/25, a 52-week low of $23.42 was recorded on 04/09/25.
Levels Of Support And Resistance For AGIO Stock
The 24-hour chart illustrates a support level at 33.15, which if violated will result in even more drops to 31.93. On the upside, there is a resistance level at 35.31. A further resistance level may holdings at 36.25.
How much short interest is there in Agios Pharmaceuticals Inc?
A steep rise in short interest was recorded in Agios Pharmaceuticals Inc stocks on 2025-06-13, growing by 0.17 million shares to a total of 4.32 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 4.16 million shares. There was a rise of 3.83%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 08, 2024 when Cantor Fitzgerald began covering the stock and recommended ‘”an Overweight”‘ rating .
